Your Cart is Empty
There was an error with PayPalClick here to try again
Thank you for your business!You should be receiving an order confirmation from Paypal shortly.Exit Shopping Cart
Welcome to the VACPN Blog!
|Posted on January 29, 2012 at 6:20 PM||comments (0)|
TO: ALL EXECUTIVE DIRECTORS
FROM: MIKE OCONNOR
RE: VACSB MEDICATION REPACKAGING TRAINING PROGRAM
On behalf of the VACSB I am pleased to be able to distribute an approved training outline to allow CSB staff at a CSB location to repackage medication that been dispensed for a specific client.
This VACSB Medication Repackaging Training Program has been approved by the Virginia Board of Pharmacy. The bullets below are important and address the required certification for staff to be able to repackage medications and meet the requirements of the relevant regulations.
* Please do not address any questions to the Board of Pharmacy. Questions should be posted on the VACSB Bulletin Board titled "Regulatory Committee". This is to both not needlessly annoy the Board but also to assure clear, complete and accurate answers that are available to our whole system. If you need simple clarification or have some general question about this material over the next couple of weeks feel free to email or call me. If it relates to something not addressed, please post the question as indicated above.
* This is a single approved program and as such you must adhere to some requirements:
* When you implement the VACSB training program in your CSB/BHA or Region, you must use only a licensed pharmacist of a registered pharmacy technician with one year’s experience [see regulations] as an instructor.
* You must register any trainers you intend to use with VACSB by sending their name, mailing address and license number to Linda at VACSB.
* You must use the attached template to award all staff who successfully complete the program the official VACSB Certificate of Completion
* You must keep a record of the names of those completing the program.
* Please make certain that your staff responsible for the process are thoroughly familiar with the regulations
* The required training should last at least 3 hours, including the practical exercise.
* Anyone conducting the training should be familiar with these new regulations as well as the required course content.
* The training program is the minimum necessary to perform this function.
* You may wish to institute additional quality assurance mechanisms.
Attached please find five attachments:
1. Two versions of the same approved course outline—one in Publisher and one in Word.
2. Certificate of Completion Template
3. New regulations permitting repackaging.
4. Instructor Registration Form Template
Caroline Juran, Executive Director of the Board of Pharmacy, was extremely helpful in this process and went above and beyond to assure full compliance with all the regulations in the most efficient way possible.
Michael D. O'Connor, L.C.S.W.
Henrico Area Mental Health & Developmental Services
10299 Woodman Road
Glen Allen, Virginia 23060
|Posted on January 29, 2012 at 6:13 PM||comments (89)|
Hope you are well. Attached is the Medicare Part D Exceptions tool.
This is the tool
that Tony Diperno, Reimbursement Specialist with Xcenda demonstrated
last week at the
VACPN Spring Retreat dinner last week.
As a reminder once you hyper link into a particular Medicare Part D
Plan the tool
provides access coverage and details of the exceptions/prior
Please distribute this reimbursement tool to your colleagues via the
VACPN site if you
Deidra Jane Massie
Area Business Specialist-Charlottesville, VA
Toll Free 888-526-2244 Ext 6148
|Posted on January 29, 2012 at 6:10 PM||comments (67)|
It was my pleasure to speak at your meeting last Thursday afternoon.
As many requested information about Parity in mental health and implications with healthcare reform, here is a link below that has some great information.
Please let me know if you need additional information.
I look forward to seeing you all again in the future.
Director, Healthcare Policy and Advocacy
Midatlantic Region-VA, WV, and Washington DC
Johnson & Johnson North America Pharmaceuticals
Confidentiality Notice: This e-mail transmission may contain confidential or legally privileged information that is intended only for the individual or entity named in the e-mail address. If you are not the intended recipient, you are hereby notified that any disclosure, copying, distribution, or reliance upon the contents of this e-mail is strictly prohibited. If you have received this e-mail transmission in error, please reply to the sender, so that Johnson & Johnson can arrange for proper delivery, and then please delete the message from your inbox. Thank you
|Posted on January 29, 2012 at 6:08 PM||comments (73)|
The latest updates from National Institute of Mental Health.